Director, General Practice Research GroupMB ChB DPH(Otago)
Director, McMaster University Sentinel and Information Collaboration (M.U.S.I.C.)
Dee Mangin is a New Zealand family physician who is currently Professor and Director of the Primary Care Research Group at the University of Otago, Christchurch. She is also the David Braley Nancy Gordon Chair in Family Medicine at McMaster University, Canada.
Her interests are rational prescribing, and the influences of science, policy and commerce on the nature of care.
Expertise spans generation of clinical evidence using randomised controlled trials, the effects of pharmaceutical company promotion to consumers and physicians, effective medicine use in older age, innovative models of general practice care and effective incorporation of evidence into patient-centered practice.
She has been a member of the Pharmaceutical and Therapeutic Products Advisory Committee.
Mangin, D. (2023). Using pilot and feasibility RCT methods: Team Approach to Polypharmacy Evaluation and Reduction (TAPER). Proceedings of the New Zealand Primary Health Care, General Practice & Rural Health Research Symposium. (pp. 11). Retrieved from https://www.otago.ac.nz/wellington/departments/primaryhealthcaregeneralpractice
Howard, M., Aubrey-Bassler, K., Drummond, N., Lussier, M.-T., Queenan, J. A., Vanstone, M., … Mangin, D. (2023). Effects of the COVID-19 pandemic on primary health care for chronic conditions in Canada: Protocol for a retrospective pre-post study using national practice-based research network data. JMIR Research Protocols, 12, e49131. doi: 10.2196/49131
Ailabouni, N. J., Weir, K. R., Brandt, N., Hanjani, L. S., Green, A., Thompson, W., … Mangin, D., … Reeve, E. (2023). Partnering with a stakeholder steering group to co-design the PRIME deprescribing conversation tool: Reflections and recommendations [Short communication]. Basic & Clinical Pharmacology & Toxicology. Advance online publication. doi: 10.1111/bcpt.13938
Mangin, D., Lamarche, L., Templeton, J. A., Salerno, J., Siu, H., Trimble, J., … Etherton-Beer, C. (2023). Theoretical underpinnings of a model to reduce polypharmacy and its negative health effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER). Drugs & Aging, 40(9), 857-868. doi: 10.1007/s40266-023-01055-z
Fikree, S., Hafid, S., Lawson, J., Agarwal, G., Griffith, L. E., Jaakkimainen, L., Mangin, D., & Howard, M. (2023). The association between patients' frailty status, multimorbidity, and demographic characteristics and changes in primary care for chronic conditions during the COVID-19 pandemic: A pre-post study. Family Practice, cmad089. Advance online publication. doi: 10.1093/fampra/cmad089